{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:05:34Z","timestamp":1784225134730,"version":"3.55.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Background<\/jats:title>\n In older patients with type 2 diabetes (T2D), physicians often de-emphasize strict glycemic control to avoid severe hypoglycemia. However, the incidence of renal impairment in diabetic octogenarians is underexplored, and the impact of glycemic control on kidney function in this age group remains unclear. This study assessed its effect on CKD development.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n Retrospective, multicenter cohort study including patients (>80 years) with T2D between 2012 and 2016, at least one annual glycated hemoglobin (HbA1c) measurement, an estimated glomerular filtration rate (GFR) \u226560 mL\/min\/1.73m\n 2<\/jats:sup>\n , and \u2265one annual GFR estimation during follow-up. Patients were classified according to glycemic control (poor and good); good control was set at HbA1c\u2009<\u20097.5%. Five-year follow-up data were collected from medical records.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The study included 1062 patients, 435 (40.96%) in the poor glycemic control group and 627 (59.04%) in the good control group. CKD incidence was significantly higher among individuals with poor control (61.61%) compared to those with good control (52.47%) (p\u2009=\u20090.003). Logistic regression analyses showed that poor control is independently associated with higher odds of CKD onset (OR: 0.87 good vs. poor control, p\u2009=\u20090.010) and accelerates its progression (time-to-CKD HR: 0.78 good vs. poor control, p\u2009=\u20090.004).<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Poor glycemic control is independently associated with CKD development and a shorter time to CKD onset, supporting its potential relevance for kidney-related outcomes in older patients with T2D. These findings highlight the need to consider glycemic control within a broader, individualized clinical approach in this population.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0353388","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:30:38Z","timestamp":1784223038000},"page":"e0353388","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between glycemic control and chronic kidney disease development in older patients with type 2 diabetes: A retrospective cohort study"],"prefix":"10.1371","volume":"21","author":[{"given":"Mar","family":"Riera-Pagespetit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gorka","family":"G\u00f3mez-Terrazas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris Xiomara","family":"Monroy-Parada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Teb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"P\u00e9rez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mir\u00f3 Ca\u00f1\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Castro-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-6202","authenticated-orcid":true,"given":"Anna","family":"Cort\u00e9s-Bosch de Basea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-2654","authenticated-orcid":true,"given":"Alejandro","family":"Rodr\u00edguez-Molinero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"9","key":"pone.0353388.ref001","first-page":"515","article-title":"Change over time in prevalence of diabetes mellitus (DM) in Spain (1999-2014)","volume":"65","author":"MJ L\u00f3pez Rey","year":"2018","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"pone.0353388.ref002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of Type 2 Diabetes \u2013 Global Burden of Disease and Forecasted Trends","volume":"10","author":"MAB Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"pone.0353388.ref003","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.regg.2017.12.003","article-title":"Tratamiento de la diabetes mellitus tipo 2 en el paciente anciano","volume":"53","author":"R G\u00f3mez-Huelgas","year":"2018","journal-title":"Rev Esp Geriatr Gerontol"},{"issue":"1","key":"pone.0353388.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1507\/endocrj.EJ17-0390","article-title":"Frailty in elderly diabetes patients","volume":"65","author":"T Yanase","year":"2018","journal-title":"Endocr J"},{"key":"pone.0353388.ref005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/TCRM.S131945","article-title":"Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis","volume":"13","author":"A Moayeri","year":"2017","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"pone.0353388.ref006","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12020-016-1014-6","article-title":"Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis","volume":"55","author":"Y Shen","year":"2017","journal-title":"Endocrine"},{"key":"pone.0353388.ref007","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"pone.0353388.ref008","doi-asserted-by":"crossref","first-page":"17088","DOI":"10.1038\/nrdp.2017.88","article-title":"Chronic kidney disease","volume":"3","author":"P Romagnani","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"pone.0353388.ref009","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000256","article-title":"Chronic kidney disease in low-income to middle-income countries: the case for increased screening","volume":"2","author":"C George","year":"2017","journal-title":"BMJ Glob Health"},{"issue":"6","key":"pone.0353388.ref010","first-page":"609","article-title":"Frailty in elderly people with chronic kidney disease","volume":"36","author":"ME Portilla Franco","year":"2016","journal-title":"Nefrologia"},{"key":"pone.0353388.ref011","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"CP Kovesdy","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"pone.0353388.ref012","doi-asserted-by":"crossref","first-page":"2333721418817396","DOI":"10.1177\/2333721418817396","article-title":"The Giant Geriatric Syndromes Are Intensified by Diabetic Complications","volume":"4","author":"A Lewandowicz","year":"2018","journal-title":"Gerontol Geriatr Med"},{"issue":"3","key":"pone.0353388.ref013","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2337\/ds20-0008","article-title":"Challenges and Strategies for Inpatient Diabetes Management in Older Adults","volume":"33","author":"AR Gosmanov","year":"2020","journal-title":"Diabetes Spectr"},{"issue":"6","key":"pone.0353388.ref014","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/dc10-2377","article-title":"Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study","volume":"34","author":"ES Huang","year":"2011","journal-title":"Diabetes Care"},{"issue":"2","key":"pone.0353388.ref015","doi-asserted-by":"crossref","first-page":"156","DOI":"10.14336\/AD.2014.0330","article-title":"Hypoglycemia in older people - a less well recognized risk factor for frailty","volume":"6","author":"AH Abdelhafiz","year":"2015","journal-title":"Aging Dis"},{"issue":"9","key":"pone.0353388.ref016","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2019536118","article-title":"Demographic perspectives on the rise of longevity","volume":"118","author":"JW Vaupel","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"pone.0353388.ref017","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/jgs.12514","article-title":"Guidelines abstracted from the American Geriatrics Society Guidelines for Improving the Care of Older Adults with Diabetes Mellitus: 2013 update","volume":"61","author":"American Geriatrics Society Expert Panel on Care of Older Adults with Diabetes Mellitus","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"pone.0353388.ref018","article-title":"Older Adults: Standards of Care in Diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"pone.0353388.ref019","volume-title":"Managing older people with type 2 diabetes","author":"N Cho","year":"2013"},{"key":"pone.0353388.ref020","article-title":"European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary","author":"AJ Sinclair","year":"2011","journal-title":"Diabetes Metab"},{"issue":"24","key":"pone.0353388.ref021","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Action to Control Cardiovascular Risk in Diabetes Study Group","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"pone.0353388.ref022","first-page":"761","article-title":"Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes","volume":"172","author":"SG Coca","year":"2012","journal-title":"Arch Intern Med"},{"issue":"1","key":"pone.0353388.ref023","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/1056-8727(94)90005-1","article-title":"The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study","volume":"8","author":"S Kawazu","year":"1994","journal-title":"J Diabetes Complications"},{"issue":"7258","key":"pone.0353388.ref024","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"IM Stratton","year":"2000","journal-title":"BMJ"},{"issue":"1","key":"pone.0353388.ref025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/nyas.12044","article-title":"Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trials","volume":"1281","author":"F Giorgino","year":"2013","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"pone.0353388.ref026","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2217\/cpr.14.46","article-title":"Chronic kidney disease in the elderly: evaluation and management","volume":"11","author":"M Mallappallil","year":"2014","journal-title":"Clin Pract (Lond)"},{"issue":"4","key":"pone.0353388.ref027","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4997\/jrcpe.2020.409","article-title":"Retrospective studies - utility and caveats","volume":"50","author":"K Talari","year":"2020","journal-title":"J R Coll Physicians Edinb"},{"key":"pone.0353388.ref028","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/nep.13706","article-title":"Where to look for the most frequent biases?","volume":"25","author":"KJ Jager","year":"2020","journal-title":"Nephrol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:30:43Z","timestamp":1784223043000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0353388"}},"subtitle":[],"editor":[{"given":"Natural Hoi Sing","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0353388","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]}}}